Bio Roundup: Nobel Prizes, Duchenne Steps, Guardant’s IPO & More | Enterpreneurship

Cancer immunotherapy is all the rage these days. The idea of harnessing the immune system to treat cancer has sparked billions of dollars in research, led to a vast matrix of clinical trials, and started to change the way how several cancers are treated. The reason: When it works, cancer immunotherapy can lead to longer-lasting results than previously thought possible.

Now the some of the field’s founding research has been recognized with one of the highest honors in science. This week, scientists credited with the discoveries leading to immunotherapies called checkpoint inhibitors were awarded the Nobel Prize in Physiology or Medicine… Read more »

Reprints | Share:

UNDERWRITERS AND PARTNERS